Volpara (ASX:VHT) Q3 2019 Quarterly Results
Volpara Health Technologies (ASX:VHT) today released its quarterly report for Q3 2018 which included a significant downgrade to its forecast Annualised Recurring Revenue (ARR). This did not come as a surprise to me, because it was known by last quarter that they would need a heroic acceleration of growth to achieve the $9 million forecast.
read more